Manufacturing and CMC at Cell 2026

Nov 12–13, 2026 London, UK ~800 attendees Website

33 organizations at Cell 2026 present work in manufacturing and CMC: 14 suppliers and service providers, 12 drug developers and 7 academic, government and non-profit bodies. Between them they bring 63 presentations to the program. Most represented: Bristol Myers Squibb (5 on the program), AstraZeneca (4 on the program), Cell and Gene Therapy Catapult (4 on the program). As of Oct 8, 2026.

All 109 organizations at Cell 2026 →

Showing 1–9 of 33 organizations

Organization	Cell 2026 Attendance
Bristol Myers Squibb Princeton, New Jersey
bms.com Large pharma Global drugmaker with marketed CAR-T cell therapies alongside medicines for cancer, immunology and cardiovascular disease.	Talk Thu Nov 12 9:25am–9:50am Advanced Technologies Driving The Next Wave Of Gene Therapy Cell and gene therapy Talk Thu Nov 12 10:15am–10:40am Phase Appropriate Analytical Strategies Including Comparability Analytics and characterizationManufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Quality Control Strategies In Advanced CGTs with Quell Therapeutics, University of Liverpool Cell and gene therapyAnalytics and characterization Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Johnson & Johnson, AstraZeneca Cell and gene therapy Talk Thu Nov 12 4:55pm–5:20pm From Vision And Concepts To Practical Execution - An Analytical Strategy And Lifecycle Execution Roadmap To Support Commercial Readiness And Operational Execution Success Analytics and characterizationManufacturing and CMC Talk Thu Nov 12 5:20pm–5:45pm One Lot, One Life: Scaling Hope for Patients with Autologous CART Treatments Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 1:55pm–2:20pm Designing An End-To-End Supply Chain For CGTs Cell and gene therapyManufacturing and CMC
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global drugmaker with medicines in oncology, cardiovascular, respiratory, immunology and rare disease, and a cell therapy pipeline.	Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies with University Medical Center Freiburg, SymphoRNA, AviadoBio Cell and gene therapy Panel Thu Nov 12 12:25pm–12:50pm The Productivity Challenge: How Can The Industry Deliver More Medicines With Less with UCB Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm Where Does Big Pharma Stand In CGTs – And What Comes Next? with Bristol Myers Squibb, Johnson & Johnson Cell and gene therapy Talk Thu Nov 12 3:05pm–3:30pm Mapping Immune Vulnerabilities: CRISPR Screens for Target Discovery Stem cells, organoids and cell models Talk Fri Nov 13 3:10pm–3:35pm Cell Line Database Development Cell line developmentDigital biomanufacturing and AI Talk Fri Nov 13 3:50pm–4:15pm Clinical Trial Designs For Advanced Therapies Outside Of Oncology Cell and gene therapy Talk Fri Nov 13 4:15pm–4:40pm Reduction Of Animal Bi-Products In Cell Cultures Cell culture and upstream processing
Cell and Gene Therapy Catapult London, UK
ct.catapult.org.uk Gov/NGO UK innovation centre helping cell and gene therapy developers with process development, GMP manufacturing space and regulatory support.	Talk Thu Nov 12 3:05pm–3:30pm Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm From Academia To Clinical Trials: A Collaborative Journey Between CGT Catapult And X Therapeutics For Successful Development And Delivery Of ATMPs Cell and gene therapy Talk Fri Nov 13 9:25am–9:50am rAAV Production Process Intensification Using Perfusion Bioreactor Technology Cell and gene therapyCell culture and upstream processing Talk Fri Nov 13 1:55pm–2:20pm Regulatory Initiatives For ATMPs In The UK Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm Beyond Silos: How Cell & Gene Therapies Fit Into The Broader Biotech & Treatment Landscape with Resolution Therapeutics, Leucid Bio Cell and gene therapy
Resolution Therapeutics London, UK
resolution-tx.com Biotech Develops regenerative macrophage therapies for inflammatory and fibrotic diseases, led by a programme in end-stage liver disease.	Talk Thu Nov 12 10:15am–10:40am Building For The Future: Phase-Appropriate CMC Strategies Manufacturing and CMC Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? with Hogan Lovells, TreeFrog Therapeutics Digital biomanufacturing and AI Panel Fri Nov 13 4:40pm–5:05pm Beyond Silos: How Cell & Gene Therapies Fit Into The Broader Biotech & Treatment Landscape with Cell and Gene Therapy Catapult, Leucid Bio Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence with Aspen Neuroscience, NHS Blood and Transplant Cell and gene therapyManufacturing and CMC Talk Fri Nov 13 5:05pm–5:30pm Developing A Regenerative Macrophage Therapy (RMT) For Fibro-Inflammatory Diseases: Challenges And Opportunities Cell and gene therapy
NHS
nhs.uk Gov/NGO The UK's publicly funded health service, whose hospitals run clinical trials and deliver approved cell and gene therapies.	Panel Thu Nov 12 5:45pm–6:10pm Solving the Capacity Crunch: How Do We Scale Advanced Therapy Operations Without Compromising Quality? Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 2:45pm–3:10pm From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients with EMEUNET, John Radcliffe Hospital Cell and gene therapy Talk Fri Nov 13 3:50pm–4:15pm CAR-T Clinical Trials In Hospitals Cell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm Patient Access In Hospitals To Administer Cell & Gene Therapies Cell and gene therapy
TreeFrog Therapeutics Bordeaux, France
treefrog.fr Biotech Develops cell therapies from pluripotent stem cells grown in its C-Stem 3D encapsulation platform, with a lead program in Parkinson's disease.	Panel Thu Nov 12 2:40pm–3:05pm The AI Reality Check: What’s Ready Now, What Isn’t, And How Do We Validate It Safely? with Hogan Lovells, Resolution Therapeutics Digital biomanufacturing and AI Panel Fri Nov 13 9:25am–9:50am Plenary Thought Leadership Panel Discussion: Turning Scientific Breakthroughs Into Sustainable Therapies – Building A Viable Business Model For CGTs with Orchard Therapeutics Cell and gene therapy Talk Fri Nov 13 11:40am–12:05pm Bridging Development and Manufacturing Through Predictive Scaling Manufacturing and CMCCell culture and upstream processing Talk Fri Nov 13 2:45pm–3:10pm Cell Therapy: From Therapeutic Potential To Sustainable Patient Access Cell and gene therapy
Autolus London, UK
autolus.com Biotech Develops and markets CAR-T cell therapies, including an approved treatment for adult acute lymphoblastic leukaemia.	Talk Thu Nov 12 3:05pm–3:30pm Harnessing Digital PCR For Rapid Sterility Testing Analytics and characterization Panel Thu Nov 12 5:20pm–5:45pm Overcoming Sterility Testing Challenges In CGT Analytical Development Analytics and characterizationCell and gene therapy Talk Fri Nov 13 5:05pm–5:30pm Developing Cutting-Edge Flow-Based Assays For Critical CMC Applications Analytics and characterizationManufacturing and CMC
AviadoBio London, UK
aviadobio.com Biotech King's College London spin-out developing gene therapies for neurodegenerative diseases such as frontotemporal dementia.	Panel Thu Nov 12 12:25pm–12:50pm Cracking In Vivo Delivery For Next-Generation Gene Therapies with University Medical Center Freiburg, SymphoRNA, AstraZeneca Cell and gene therapy Talk Thu Nov 12 2:40pm–3:05pm Manufacture Of AVB-406, A BBB-Crossing AAV Vector For MAPT Knockdown In Alzheimer's Disease Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm Leveraging Platform-Based RNA Silencing To Accelerate Rare Disease Therapeutic Development Cell and gene therapy
INmune Bio Boca Raton, Florida
inmunebio.com Biotech Clinical-stage company developing immune-targeted therapies, including a TNF inhibitor for neurological disease and an umbilical cord MSC therapy.	Talk Thu Nov 12 9:25am–9:50am Designing Large Scale Cell Therapies For Real-World Access Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 1:55pm–2:20pm Closing The Gap: Connecting Upstream And Downstream Bioprocessing In Cell-Based Therapies with Quell Therapeutics, Technical University of Denmark Cell culture and upstream processingCell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm MSC Therapies: From Decades Of Challenges To Commercial Approval Cell and gene therapyStem cells, organoids and cell models